Skip to main content
1003-2006, 1005-2014, 1004-2009, 1006-2018, 1004-2010, 1001-2001, 1006-2020, 1006-2019, 1001-2002, 1005-2015, 1006-2021, 1004-2011, 1005-2016, 1006-2022, 1002-2005, 1002-2004, 1006-2023, 1006-2024, 1003-2007, 1006-2025, 1004-2012, 1004-2013, 1006-2027, 1001-2003, 1006-2026, 1003-2008, 1005-2017, 1006-2028
class com.aha.ucm.component.cis.TagListPageData=[,docNativeURL=null,docName=UCM_503619,docStatus=RELEASED,dOutDate=null,docSSFileName=UCM_503619_2019-Guideline-on-the-Primary-Prevention-of-Cardiovascular-Disease.jsp,docTitle=2019 Guideline on the Primary Prevention of Cardiovascular Disease,xWebsites=professional,dDocAuthor=stacy.ragsdale,xNextReviewDate=09/22/2016 5:42 PM,xTier1=36,xFeaturedItem=No,xElectronicRegistration=No,UserLocale=null,xSubCategory=,dpEvent=null,xComments=The purpose of this guideline is to review and consolidate existing recommendations into a single guidance document focused on the primary prevention of atherosclerotic cardiovascular disease (ASCVD).,NoHttpHeaders=null,UserTimeZone=null,xRegionDefinition=GENERIC_RD_COL_1,xVideoRenditions=,xSnippetItem=,xNotes=,UserDateFormat=null,encodeDocUrl=null,isDocProfileDone=null,xKeywords=guidelines, antihypertensive agents, aspirin, atherosclerosis, atherosclerotic cardiovascular disease, atrial fibrillation, behavior modification, behavior therapy, blood cholesterol, blood pressure, body mass, index, cardiovascular team-based care, cardiovascular, cardiovascular disease, cholesterol, chronic kidney disease, coronary artery calcium score, coronary disease, coronary heart disease, cost, diet, dietary patterns, dietary fats, dietary sodium, dyslipidemia, e-cigarettes, exercise, healthcare disparities, health services accessibility, heart failure, hypertension, LDL-cholesterol, diabetes mellitus, lifestyle, lipids, measurement, myocardial infarction, nicotine, nonpharmacological treatment, nutrition, physical activity, prejudice, primary prevention, psychosocial deprivation, public health, quality indicators, quality measurement, risk assessment, risk-enhancing factors, risk factors, risk reduction, risk reduction discussion, risk treatment discussion, secondhand smoke, sleep, smoking, smoking cessation, social determinants of health, socioeconomic factors, statin therapy, systems of care, tobacco, tobacco smoke pollution, treatment adherence, treatment outcomes, type 2 diabetes mellitus, waist circumference, weight loss,xTier2=,refreshSubMonikers=null,xEditorStepReassignedUsers=null,xLinkTextToDisplay=,dDocAccount=WCM/SOP/SMD,xEndDateTime=null,xClbraAliasList=null,ClientEncoding=null,xCpdIsLocked=0,xUsageRightsDate=null,xModifyDate=03/17/2019 7:59 PM,xTier3=,xEventDate=null,dSubscriptionType=null,xCopyright=No,xPackagedConversions=,dSubscriptionAlias=null,xStorageRule=,dpName=null,xDepartment=Science Operations,dStatus=RELEASED,dPublishType=,xCopyrightDetails=,xSubType=64,isDocProfileUsed=null,xWebsiteObjectType=Data File,xWebFlag=,xSeeAlsoLinks=,xClbraUserList=null,xPartitionId=,xCpdIsTemplateEnabled=0,xLinkWebAddress=,xDontShowInListsForWebsites=,xStartDateTime=null,dInDate=03/17/2019 7:10 PM,xWebsiteSection=professional:1463,dDocName=UCM_503619,dpAction=null,dRevLabel=2,dSecurityGroup=AHAMAH-Public,xCategory=,refreshMonikers=null,xDamConversionType=,dDocFormats=null,xAssociatedImage=,dDocType=SingleColumn,xBusinessOwner=Business Owner,xUploadDate=null,xDiscussionCount=0,xMainFlowEntryCriteria=True,xItemInformation=,xUsageRights=,xDiscussionType=N/A,xRecipeTaxonomy=,dSubscriptionID=null,dOriginalName=UCM_503619.xml,xProfileTrigger=SingleColumn,dLocation=,dRevisionID=2,dPublishState=,dReleaseState=Y,xTrashDeleter=null,dMessage=,dWebExtension=xml,dExtension=xml,dProcessingState=Y,xTrashDeleteName=null,dIsCheckedOut=0,xForceFolderSecurity=null,dRevClassID=503619,dIsPrimary=1,dFileSize=25110,dIndexerState=,dFlag1=,xviaAddNewContentService=,dIsWebFormat=0,xCollectionID=null,dRevRank=0,xReadOnly=null,dCheckoutUser=,dFormat=Application/xml,dWorkflowState=,dDocID=1883921,dRendition2=,dRendition1=,xInhibitUpdate=null,dReleaseDate=03/17/2019 8:00 PM,xTrashDeleteLoc=null,dCreateDate=03/17/2019 7:59 PM,xHidden=null,labelTier1=ScienceNews,labelTier2=,labelTier3=,labelTier4=,mobileNavURL=DEFAULT2_VALUE_FROM_getDataForAdvanceSearch,xContactPhoneNumber=,xContactEmailAddress=,xContactName=,xATGRolesDisciplines=,xPublishDate=03/17/2019 7:00 PM,xRobotParameter=,xCommunities=1003-2006, 1005-2014, 1004-2009, 1006-2018, 1004-2010, 1001-2001, 1006-2020, 1006-2019, 1001-2002, 1005-2015, 1006-2021, 1004-2011, 1005-2016, 1006-2022, 1002-2005, 1002-2004, 1006-2023, 1006-2024, 1003-2007, 1006-2025, 1004-2012, 1004-2013, 1006-2027, 1001-2003, 1006-2026, 1003-2008, 1005-2017, 1006-2028,xMembershipLevel=,rsCalories=null,rsSodium=null,rsRecipeTaxonomy=null,rsServings=null,rsTotalTime=null,rsTotalFat=null,rsTotalCarbs=null,rsFeaturedImage=null,xDisplayComments=

2019 CVD Primary Prevention Guideline

Runners-approaching-finish-line-during-marathon-or-5k-race_750x500
  • The purpose of this guideline is to review and consolidate existing recommendations into a single guidance document focused on the primary prevention of atherosclerotic cardiovascular disease (ASCVD).
  • This guideline includes newly generated recommendations for aspirin use, and tobacco use, in addition to recommendations related to team-based care, shared decision-making, exercise and physical activity, and assessment of social determinants of health.
  • Recommendations for lifestyle and other factors that affect cardiovascular risk are provided to create a comprehensive yet targeted ACC/AHA guideline on primary prevention of ASCVD.

Read the full article in Circulation

Related Videos

Related Science